Actively Recruiting
Innate Immunity in Allergic Asthma
Led by University of Central Florida · Updated on 2024-12-06
100
Participants Needed
1
Research Sites
188 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
CONDITIONS
Official Title
Innate Immunity in Allergic Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be at least 18 years of age
- Participants may be healthy without allergic disease, have clinically diagnosed allergies, or have clinically diagnosed asthma
You will not qualify if you...
- Pregnant women are excluded
- Prisoners are excluded
- Individuals currently suffering from any acute infections are excluded
- Individuals known to suffer from light-headedness are excluded
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Central Florida
Orlando, Florida, United States, 32816
Actively Recruiting
Research Team
A
Amoy Fraser, PhD, CCRP, PMP
CONTACT
E
Erica Martin, B.S.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here